Download the amazing global Makindo app:
Android |
Apple
MEDICAL DISCLAIMER: Educational use only. Not for diagnosis or management. See below for full disclaimer.
Rasagiline
๐ About Rasagiline
Always check the BNF entry here for latest prescribing advice.
MAO-B inhibitor used in the management of Parkinsonโs disease.
Approx. 5ร more potent than selegiline.
โ๏ธ Mode of Action
Monoamine oxidase-B (MAO-B) inhibitor.
Reduces dopamine breakdown in the brain โ prolongs dopaminergic activity.
๐ฏ Indication & Dose
Indication: Parkinsonโs disease, either:
โ Monotherapy in early disease, OR
โ Adjunct to levodopa (co-beneldopa / co-careldopa) to reduce โend-of-doseโ fluctuations.